Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In‐Stent Restenosis

Documenti analoghi

• Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis
  di: Saleha Khattak, et al.
  Pubblicazione: (2026)
• Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year
  di: Sebastian König, et al.
  Pubblicazione: (2025)
• Incremental Value of Non‐Gated Chest CT Coronary Artery Calcium Score in Predicting Major Adverse Cardiovascular Events by GRACE Score After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
  di: Zhaoyuan Xing, et al.
  Pubblicazione: (2025)
• Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes
  di: Mauricio Rigodanzo Mocha, et al.
  Pubblicazione: (2025)
• The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention
  di: Laura Lappalainen, et al.
  Pubblicazione: (2026)